Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ASTELLAS PHARMA INC
01/12 ASTELLAS PHARMA : Launches Second Phase of Global Campaign on CNN
01/10 ASTELLAS PHARMA : Terminates Agreement with UMN Pharma for Cell Culture Based In..
2016 ASTELLAS PHARMA : Completes Acquisition of Ganymed Pharmaceuticals
2016 ASTELLAS PHARMA : to Present at J.P. Morgan Healthcare Conference
2016 ASTELLAS PHARMA : Announces FDA Fast Track Designation for ASP0892, DNA Vaccine ..
2016 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares
2016 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares
2016 ASTELLAS PHARMA : to Present at J.P. Morgan Healthcare Conference
2016 AMGEN : seeks to market osteoporosis drug in Japan
2016 ASTELLAS PHARMA : New Cell Proliferation Study Findings Recently Were Reported b..
2016 PFIZER : and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTAN..
2016 ASTELLAS PHARMA : Oncorus®, Inc. Announces Additional Series A Financing Support..
2016 ASTELLAS PHARMA : Completes Acquisition of Ganymed Pharmaceuticals
2016 ASTELLAS PHARMA : Marketing Approval of LINZESS, Treatment for Irritable Bowel S..
2016 ASTELLAS PHARMA : Amgen astellas and astellas announce submission of application..
2016 ASTELLAS PHARMA : Announces FDA Fast Track Designation for ASP0892, DNA Vaccine ..
2016 ASTELLAS PHARMA : Marketing Approval of LINZESS®, Treatment for Irritable Bowel ..
2016 PFIZER : and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTAN..
2016 ASTELLAS PHARMA : Sysmex, Astellas and Daiichi Sankyo Sign Memorandum of Underst..
2016 ASTELLAS PHARMA : Pfizer and Astellas Announce Top-Line Results from Phase 4 PLA..
2016 ASTELLAS PHARMA : Multi-national pharma company reduces raw materials QC costs b..
2016 ASTELLAS PHARMA : Research & Development Meeting Highlights
2016 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
2016 ASTELLAS PHARMA : Immunomic Therapeutics Announces Expansion of IP Portfolio
2016 ASTELLAS PHARMA : Initiatives to Pursue Operational Excellence
2016 CASE STUDY : Application of SORS (RapID) to In-Container Testing of Raw Material..
2016 ASTELLAS PHARMA : Antihypertensive Drug 'Micatrio Combination Tablets'
2016 ASTELLAS PHARMA : Antihypertensive Drug "Micatrio® Combination Tablets"
2016 ASTELLAS PHARMA : GUINNESS WORLD RECORDS Title Achieved for Organ Donor Registra..
2016 ASTELLAS PHARMA : GUINNESS WORLD RECORDSTM Title Achieved for Organ Donor Regist..
2016 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI enza..
2016 ASTELLAS PHARMA : to Acquire Ganymed Pharmaceuticals
2016 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 187KB)
2016 ASTELLAS PHARMA : Announces Acquisition of Own Shares
2016 ASTELLAS PHARMA : to acquire German pharmaceutical company
2016 ASTELLAS PHARMA : to acquire German pharmaceutical company
2016 ASTELLAS PHARMA : Reports First Half FY2016 Financial Results, Revises Fiscal Ye..
2016 ASTELLAS PHARMA : to Acquire Ganymed Pharmaceuticals -Acquisition Would Expand '..
2016 ASTELLAS PHARMA : Reports First Half FY2016 Financial Results, Revises Fiscal Ye..
2016 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 175KB)
2016 ASTELLAS PHARMA : Findings in Kidney Function Reported from Astellas Pharma, Inc..
2016 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI (enz..
2016 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI in A..
2016 ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of ..
2016 ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of ..
2016 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
2016 ASTELLAS PHARMA : Termination of Business Transfer Discussion with Kaketsuken
2016 INSPYR THERAPEUTICS, INC. (OTCQB : NSPX) Files An 8-K
2016 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
2016 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
2016 ASTELLAS PHARMA : Investigators from Astellas Pharma, Inc. Release New Data on M..
2016 STUDIES CONDUCTED AT ASTELLAS PHARMA : Potential of urinary nephrin as a biomark..
2016 ASTELLAS PHARMA : Johns Hopkins licensing revenue spikes in fiscal 2016
2016 ASTELLAS PHARMA : Chromocell and Astellas Announce FDA Fast Track Designation an..
2016 SEATTLE GENETICS : and Agensys, an Affiliate of Astellas, Highlight Enfortumab V..
2016 ASTELLAS PHARMA : Filed Lawsuit against Patent Infringement of Myrbetriq in the ..
2016 ASTELLAS PHARMA : Filed Lawsuit against Patent Infringement of Myrbetriq® in the..
2016 ASTELLAS PHARMA : Donates 6 Wheelchair Vans through the Flying Star Fund, an Emp..
2016 ASTELLAS PHARMA : Maruho and Astellas Enter License Agreement for the Developmen..
2016 ASTELLAS PHARMA : Approval for Manufacturing and Marketing of 'Micatrio Combinat..
2016 ASTELLAS PHARMA : Receives Approval for Kiklin® Granules, a Treatment for Hyperp..
2016 ASTELLAS PHARMA : Approval for Manufacturing and Marketing of "Micatrio® Combina..
2016 ASTELLAS PHARMA INC : ex-dividend day for interim dividend
2016 VICAL INCORPORATED : and Astellas Announce Topline Results from a Phase 2 Study ..
2016 Hang Lung Properties to Bring in Conrad Hotel Project
2016 ASTELLAS PHARMA : Selected as a Dow Jones Sustainability Asia Pacific Index Comp..
2016 ASTELLAS PHARMA : and MPM debut DigiTx Partners, a digital health investment com..
2016 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. in the Area of Nuclear Mag..
2016 ASTELLAS PHARMA : Study Results from Astellas Pharma, Inc. Provide New Insights ..
2016 ASTELLAS PHARMA : donates ambulances on First Aid Day (September 9)
2016 ASTELLAS PHARMA : and World Transplant Games Federation Announce Launch of Fit f..
2016 ASTELLAS PHARMA : Announces Personnel Changes
2016 ASTELLAS PHARMA : Announces Personnel Changes (pdf 47KB)
2016 ASTELLAS PHARMA : and World Transplant Games Federation Announce Launch of Fit f..
2016 ASTELLAS PHARMA : Farma Brasil Ranked Among 20 Greatest Workplaces in Brazil
1  2  3  4  5  6  7Next
Advertisement
Financials ( JPY)
Sales 2017 1 320 948 M
EBIT 2017 275 000 M
Net income 2017 201 824 M
Finance 2017 471 719 M
Yield 2017 2,17%
P/E ratio 2017 16,59
P/E ratio 2018 15,72
EV / Sales 2017 2,24x
EV / Sales 2018 2,05x
Capitalization 3 427 810 M
More Financials
Chart ASTELLAS PHARMA INC
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Full-screen chart
Technical analysis trends ASTELLAS PHARMA INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 1 937  JPY
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yoshihiko Hatanaka President, CEO & Representative Director
Masafumi Nogimori Chairman
Yasumasa Masuda Chief Financial Officer
Mitsunori Matsuda Senior Executive Officer & President-Technology
Yoshiro Miyokawa Representative Director & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC-2.12%30 247
JOHNSON & JOHNSON-0.53%311 773
ROCHE HOLDING LTD.2.75%203 077
PFIZER INC.0.12%197 343
NOVARTIS AG-1.48%187 856
MERCK & CO., INC.5.89%171 880
More Results